A recent study reports that ES936, an NQO1 inhibitor, enhances TRAIL-induced apoptosis in endometrial carcinoma Ishikawa cells [14], and inhibition of NQO1 activity leads to the effect of SPL-A on TRAIL-induced apoptosis [15]. Here, NQO1 is linked to endometrial carcinoma.